SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 219 filers reported holding SEATTLE GENETICS INC in Q2 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $7,789,000 | +23.3% | 75,450 | +2.0% | 0.05% | +11.4% |
| Q3 2019 | $6,317,000 | +789.7% | 73,977 | +618.9% | 0.04% | +780.0% |
| Q2 2019 | $710,000 | +25.0% | 10,291 | +32.8% | 0.01% | +25.0% |
| Q1 2019 | $568,000 | +88.1% | 7,748 | +46.0% | 0.00% | +33.3% |
| Q4 2018 | $302,000 | +18.0% | 5,308 | +60.6% | 0.00% | +50.0% |
| Q3 2018 | $256,000 | +22.5% | 3,306 | -17.2% | 0.00% | 0.0% |
| Q2 2018 | $209,000 | 0.0% | 3,995 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $209,000 | +124.7% | 3,995 | +128.9% | 0.00% | +100.0% |
| Q4 2017 | $93,000 | +14.8% | 1,745 | +15.9% | 0.00% | 0.0% |
| Q3 2017 | $81,000 | -24.3% | 1,506 | -27.6% | 0.00% | 0.0% |
| Q2 2017 | $107,000 | -24.6% | 2,081 | -7.8% | 0.00% | -50.0% |
| Q1 2017 | $142,000 | +18.3% | 2,257 | -0.8% | 0.00% | 0.0% |
| Q4 2016 | $120,000 | -35.8% | 2,275 | -34.6% | 0.00% | -33.3% |
| Q3 2016 | $187,000 | +90.8% | 3,480 | +43.8% | 0.00% | +50.0% |
| Q2 2016 | $98,000 | +14.0% | 2,420 | -0.3% | 0.00% | 0.0% |
| Q1 2016 | $86,000 | -37.7% | 2,428 | -22.0% | 0.00% | -33.3% |
| Q4 2015 | $138,000 | +24.3% | 3,113 | +8.0% | 0.00% | +50.0% |
| Q3 2015 | $111,000 | -14.6% | 2,882 | +6.7% | 0.00% | 0.0% |
| Q2 2015 | $130,000 | +80.6% | 2,700 | +33.7% | 0.00% | +100.0% |
| Q1 2015 | $72,000 | +4.3% | 2,019 | -5.4% | 0.00% | -50.0% |
| Q4 2014 | $69,000 | +11.3% | 2,135 | +27.7% | 0.00% | 0.0% |
| Q3 2014 | $62,000 | -4.6% | 1,672 | -1.5% | 0.00% | 0.0% |
| Q2 2014 | $65,000 | -8.5% | 1,697 | +9.2% | 0.00% | 0.0% |
| Q1 2014 | $71,000 | -60.6% | 1,554 | -65.6% | 0.00% | -66.7% |
| Q4 2013 | $180,000 | +68.2% | 4,514 | +85.5% | 0.01% | +50.0% |
| Q3 2013 | $107,000 | +55.1% | 2,433 | +10.5% | 0.00% | +100.0% |
| Q2 2013 | $69,000 | – | 2,202 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |